Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03245411 · ClinicalTrials.gov registry record · NA

Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

A NA study of Cancer, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT03245411: Recruiting NA study of Cancer, sponsored by Thomas Jefferson University.

NCT03245411 is a NA study of Cancer that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 110 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03245411, a NA study of Cancer, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention

Study Locations (1)

Pennsylvania

  • Albert Einstein Healthcare Network - Philadelphia

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2017-07-20
Est. Completion 2025-12-20
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT03245411

The ClinicalTrials.gov registry entry for NCT03245411 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.

NCT03245411 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03245411 about?

NCT03245411 is a clinical study titled "Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients". Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among ...

What is the current status of trial NCT03245411?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2017-07-20. Estimated completion is 2025-12-20.

What conditions does trial NCT03245411 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03245411?

The interventions under investigation include: Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03245411?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03245411 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.